search
Back to results

An Evaluation of Zinc Status Biomarkers

Primary Purpose

Inflammation, Oxidative Stress

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Diet zinc
Sponsored by
UCSF Benioff Children's Hospital Oakland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Inflammation focused on measuring Zinc, DNA Integrity, Gene Expression, diet zinc, nutrition requirements

Eligibility Criteria

18 Years - 50 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • willing to limit food and beverage intake to that provided by the study
  • willing to discontinue consumption of alcoholic beverages during the study
  • has an operative understanding of English
  • no plans to move from the area during the study period

Exclusion Criteria:

  • chronic or acute metabolic disease (i.e., diabetes or asthma)
  • taking medications for a metabolic disorder
  • evidence of alcohol abuse or use of illicit drugs

Sites / Locations

  • Children's Hospital Oakland Research Institute

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

diet zinc

Arm Description

3 dietary zinc levels: 6 mg/d, 10 mg/d and 25 mg supplemental zinc/d

Outcomes

Primary Outcome Measures

Change in the percent of leukocytic DNA strand breaks
Baseline measurements were made upon entry into the study. Subsequent measurements were made after 2 weeks on a low zinc diet (6 mg/d), 4 weeks on a moderate zinc intake (10 mg/d) and after 3 weeks of consuming a 25 mg zinc supplement.

Secondary Outcome Measures

Cellular zinc biomarkers
Specific measurements included the gene expression of zinc transporters, the in vitro uptake of leukocytic radioactive Zn, and a comprehensive serum metabolomic and proteomic analysis.

Full Information

First Posted
August 4, 2016
Last Updated
November 20, 2020
Sponsor
UCSF Benioff Children's Hospital Oakland
search

1. Study Identification

Unique Protocol Identification Number
NCT02861352
Brief Title
An Evaluation of Zinc Status Biomarkers
Official Title
Testing Novel Biomarkers of Zinc Status for Use in Human Zinc Supplementation Trials
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
February 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
UCSF Benioff Children's Hospital Oakland

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the effect of a moderate decrease in dietary zinc on DNA strand breaks and other cellular zinc biomarkers.
Detailed Description
Assessing the zinc status of humans has proven to be difficult because of the unique physiological features of zinc homeostasis. Animal and human studies show that a small, vulnerable pool of cellular zinc is sensitive to changes in dietary zinc. The protein, Metallothionein (MT), is made within cells to stabilize this transient zinc pool and to provide a means to 'park' a small zinc reserve. The overall goal is to develop a new method for measuring MT in cells and to assess other cellular responses to changes in small changes in dietary zinc. Culture models of zinc deficiency and excess have been developed and used to test the response of cellular MT levels and mineralization to changes in zinc availability. In Phase II, the changes in the expression of leukocytic zinc transporters and the cellular in vitro uptake of isotopic zinc will be measured. Healthy men will be recruited to participate in a 6-week feeding trial to be followed by a 3-week recovery period. The results of this study will determine if potential new cellular zinc biomarkers respond to changes in zinc status when the men are fed an additional 4 mg zinc/d incorporated into a rice-based meal. These findings will provide essential, new information for designing an efficacy trial of biofortified rice and the zinc status of infants and young children.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammation, Oxidative Stress
Keywords
Zinc, DNA Integrity, Gene Expression, diet zinc, nutrition requirements

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
18 (Actual)

8. Arms, Groups, and Interventions

Arm Title
diet zinc
Arm Type
Experimental
Arm Description
3 dietary zinc levels: 6 mg/d, 10 mg/d and 25 mg supplemental zinc/d
Intervention Type
Other
Intervention Name(s)
Diet zinc
Intervention Description
4 mg zinc, as zinc sulfate, was added to a controlled diet; 25 mg supplemental zinc was given during the final recovery period when an ad lib diet was consumed
Primary Outcome Measure Information:
Title
Change in the percent of leukocytic DNA strand breaks
Description
Baseline measurements were made upon entry into the study. Subsequent measurements were made after 2 weeks on a low zinc diet (6 mg/d), 4 weeks on a moderate zinc intake (10 mg/d) and after 3 weeks of consuming a 25 mg zinc supplement.
Time Frame
Change in DNA strand breaks measured at baseline, 2, 4, and 3 week intervals with changes in diet zinc
Secondary Outcome Measure Information:
Title
Cellular zinc biomarkers
Description
Specific measurements included the gene expression of zinc transporters, the in vitro uptake of leukocytic radioactive Zn, and a comprehensive serum metabolomic and proteomic analysis.
Time Frame
At baseline and at 3 time points during the 9 week study: after 2, 6, and 9 weeks.

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: willing to limit food and beverage intake to that provided by the study willing to discontinue consumption of alcoholic beverages during the study has an operative understanding of English no plans to move from the area during the study period Exclusion Criteria: chronic or acute metabolic disease (i.e., diabetes or asthma) taking medications for a metabolic disorder evidence of alcohol abuse or use of illicit drugs
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janet C King, Ph.D.
Organizational Affiliation
UCSF Benioff Children's Hospital Oakland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital Oakland Research Institute
City
Oakland
State/Province
California
ZIP/Postal Code
94609
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28003206
Citation
Zyba SJ, Shenvi SV, Killilea DW, Holland TC, Kim E, Moy A, Sutherland B, Gildengorin V, Shigenaga MK, King JC. A moderate increase in dietary zinc reduces DNA strand breaks in leukocytes and alters plasma proteins without changing plasma zinc concentrations. Am J Clin Nutr. 2017 Feb;105(2):343-351. doi: 10.3945/ajcn.116.135327. Epub 2016 Dec 21. Erratum In: Am J Clin Nutr. 2017 Dec;106(6):1539.
Results Reference
derived

Learn more about this trial

An Evaluation of Zinc Status Biomarkers

We'll reach out to this number within 24 hrs